2019 Opioid Induced Bowel Dysfunction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Opioid Induced Bowel Dysfunction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Opioid Induced Bowel Dysfunction. It presents in-depth analysis of Opioid Induced Bowel Dysfunction clinical trials across markets and companies. The research work is for providing complete understanding into trends in Opioid Induced Bowel Dysfunction.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Opioid Induced Bowel Dysfunction clinical trials by-
The research work is prepared through extensive and continuous research on Opioid Induced Bowel Dysfunction trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Opioid Induced Bowel Dysfunction clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Opioid Induced Bowel Dysfunction trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Opioid Induced Bowel Dysfunction patients are identified
- The report includes panorama of Opioid Induced Bowel Dysfunction clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Opioid Induced Bowel Dysfunction clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Opioid Induced Bowel Dysfunction Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Opioid Induced Bowel Dysfunction Clinical Trials by Region
2.2.2 Average Enrollment of Opioid Induced Bowel Dysfunction Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Opioid Induced Bowel Dysfunction Treatment, 2019
3. REGION WISE OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIALS
3.1 Asia Pacific Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.2 Europe Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.3 North America Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.4 Middle East and Africa Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.5 South and Central America Opioid Induced Bowel Dysfunction Clinical Trials by Country
4. OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIAL TRENDS
4.1 Start Year wise Opioid Induced Bowel Dysfunction Clinical Trials
4.2 Phase wise Opioid Induced Bowel Dysfunction Clinical Trials
4.3 Trial Status wise Opioid Induced Bowel Dysfunction Clinical Trials
4.4 Trial Type wise Opioid Induced Bowel Dysfunction Clinical Trials
5. OPIOID INDUCED BOWEL DYSFUNCTION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Year
5.2 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Phase
5.3 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Status
5.4 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Type of Trial
6. COMPANIES PARTICIPATING IN OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIALS
6.1 Opioid Induced Bowel Dysfunction Trials by Sponsor Type
6.2 Opioid Induced Bowel Dysfunction Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Opioid Induced Bowel Dysfunction Trials- Phase
7.2 Opioid Induced Bowel Dysfunction Trials- Phase
7.3 Opioid Induced Bowel Dysfunction Trials- Phase
7.4 Opioid Induced Bowel Dysfunction Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Opioid Induced Bowel Dysfunction Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Opioid Induced Bowel Dysfunction Clinical Trials by Region
2.2.2 Average Enrollment of Opioid Induced Bowel Dysfunction Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Opioid Induced Bowel Dysfunction Treatment, 2019
3. REGION WISE OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIALS
3.1 Asia Pacific Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.2 Europe Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.3 North America Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.4 Middle East and Africa Opioid Induced Bowel Dysfunction Clinical Trials by Country
3.5 South and Central America Opioid Induced Bowel Dysfunction Clinical Trials by Country
4. OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIAL TRENDS
4.1 Start Year wise Opioid Induced Bowel Dysfunction Clinical Trials
4.2 Phase wise Opioid Induced Bowel Dysfunction Clinical Trials
4.3 Trial Status wise Opioid Induced Bowel Dysfunction Clinical Trials
4.4 Trial Type wise Opioid Induced Bowel Dysfunction Clinical Trials
5. OPIOID INDUCED BOWEL DYSFUNCTION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Year
5.2 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Phase
5.3 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Status
5.4 Average Enrollment in Opioid Induced Bowel Dysfunction Trials by Type of Trial
6. COMPANIES PARTICIPATING IN OPIOID INDUCED BOWEL DYSFUNCTION CLINICAL TRIALS
6.1 Opioid Induced Bowel Dysfunction Trials by Sponsor Type
6.2 Opioid Induced Bowel Dysfunction Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Opioid Induced Bowel Dysfunction Trials- Phase
7.2 Opioid Induced Bowel Dysfunction Trials- Phase
7.3 Opioid Induced Bowel Dysfunction Trials- Phase
7.4 Opioid Induced Bowel Dysfunction Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Opioid Induced Bowel Dysfunction Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 5: Europe – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 7: North America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 9: Opioid Induced Bowel Dysfunction Clinical Trials by Phase
Figure 10: Opioid Induced Bowel Dysfunction Clinical Trials by Trial Status
Figure 11: Opioid Induced Bowel Dysfunction Clinical Trials by Type
Figure 12: Opioid Induced Bowel Dysfunction Clinical Trials by Sponsor Type
Figure 13: Opioid Induced Bowel Dysfunction Clinical Trials by Leading Sponsors
Figure 14: Opioid Induced Bowel Dysfunction Average Enrollment by Phase
Figure 15: Opioid Induced Bowel Dysfunction Average Enrollment by Trial Status
Figure 16: Opioid Induced Bowel Dysfunction Average Enrollment by Type
Figure 17: Opioid Induced Bowel Dysfunction- Average Enrolment by Type of Sponsors
Figure 18: Opioid Induced Bowel Dysfunction- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Opioid Induced Bowel Dysfunction Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 5: Europe – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 7: North America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Figure 9: Opioid Induced Bowel Dysfunction Clinical Trials by Phase
Figure 10: Opioid Induced Bowel Dysfunction Clinical Trials by Trial Status
Figure 11: Opioid Induced Bowel Dysfunction Clinical Trials by Type
Figure 12: Opioid Induced Bowel Dysfunction Clinical Trials by Sponsor Type
Figure 13: Opioid Induced Bowel Dysfunction Clinical Trials by Leading Sponsors
Figure 14: Opioid Induced Bowel Dysfunction Average Enrollment by Phase
Figure 15: Opioid Induced Bowel Dysfunction Average Enrollment by Trial Status
Figure 16: Opioid Induced Bowel Dysfunction Average Enrollment by Type
Figure 17: Opioid Induced Bowel Dysfunction- Average Enrolment by Type of Sponsors
Figure 18: Opioid Induced Bowel Dysfunction- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Opioid Induced Bowel Dysfunction Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 5: Europe – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 7: North America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Opioid Induced Bowel Dysfunction Average Enrollment by Phase
Table 15: Opioid Induced Bowel Dysfunction Average Enrollment by Trial Status
Table 16: Opioid Induced Bowel Dysfunction Average Enrollment by Type
Table 17: Opioid Induced Bowel Dysfunction- Average Enrolment by Type of Sponsors
Table 18: Opioid Induced Bowel Dysfunction- Enrolment by Leading Sponsors
Table 1: Opioid Induced Bowel Dysfunction Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 5: Europe – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 7: North America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Opioid Induced Bowel Dysfunction Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Opioid Induced Bowel Dysfunction Average Enrollment by Phase
Table 15: Opioid Induced Bowel Dysfunction Average Enrollment by Trial Status
Table 16: Opioid Induced Bowel Dysfunction Average Enrollment by Type
Table 17: Opioid Induced Bowel Dysfunction- Average Enrolment by Type of Sponsors
Table 18: Opioid Induced Bowel Dysfunction- Enrolment by Leading Sponsors
